Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fas expression prevents cholangiocarcinoma tumor growth.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract - 1 Jan 1999

Pickens A, Pan G, McDonald J M, Vickers S M

Abstract excerpt

Cholangiocarcinoma continues to have a dismal prognosis with an overall survival rate of less than 10%. An increased understanding of the molecular oncogenesis of this tumor is needed. Fas/APO-1 (CD95) receptor and Fas ligand have been implicated as key factors in apoptosis. In this study we have examined the role of the Fas receptor in the growth of cholangiocarcinoma. The purpose of this study was to evaluate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to fas Receptor
Share to Antigens, Surface
Share to Cholangiocarcinoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Coloring Agents

Share to Fas Ligand Protein

Share to In Situ Nick-End Labeling

Share to Keratins

Share to Transplantation, Heterologous

Source

Identifiers

PMID: 10482689
DOI: 10.1016/s1091-255x(99)80053-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fas expression prevents cholangiocarcinoma tumor growth.PMID 10482689Read ↗

IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma.Semantic proximity Read ↗

Primary and Malignant Cholangiocytes Undergo CD40 Mediated Fas Dependent Apoptosis, but Are Insensitive to Direct Activation with Exogenous Fas LigandSemantic proximity Read ↗

Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell lineSemantic proximity Read ↗

Up-regulation of Fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillanceSemantic proximity Read ↗

Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cellsSemantic proximity Read ↗

Expression and antitumor effects of TRAIL in human cholangiocarcinoma.Semantic proximity Read ↗

Hepatitis C virus protein expression induces apoptosis in HepG2 cells.Semantic proximity Read ↗

Overexpression of the mouse Fas gene in human Hep3B hepatoma cells overcomes their resistance to Fas-mediated apoptosis.Semantic proximity Read ↗

Hepatic expression of SV40 small-T antigen blocks the in vivo CD95-mediated apoptosis.Semantic proximity Read ↗

Increased Ras Expression and Caspase-Independent Neuroblastoma Cell Death: Possible Mechanism of Spontaneous Neuroblastoma RegressionSemantic proximity Read ↗

Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci.Semantic proximity Read ↗

Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.